本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Checkpoint Therapeutics, Inc.

4.16
+0.00500.12%
成交量:66.85万
成交额:278.18万
市值:3.48亿
市盈率:-2.93
高:4.17
开:4.16
低:4.15
收:4.15
数据加载中...
2021/06/11

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/11

重要事件披露

8-K - Current report
2021/05/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/09

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/17

重要事件披露

8-K - Current report
2020/12/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/07

重要事件披露

8-K - Current report
2020/09/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/21

重要事件披露

8-K - Current report
2020/09/18

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/09/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals